Login to Your Account

FDA Grants Corixa's Appeal; Bexxar Will Go Before ODAC

By Kim Coghill

Friday, June 28, 2002
Corixa Corp. won an appeal against an FDA decision issued earlier this year that required additional clinical trials in order to market the cancer drug Bexxar. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription